BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. World J Gastroenterol 2014; 20(1): 183-192 [PMID: 24415871 DOI: 10.3748/wjg.v20.i1.183]
URL: https://www.wjgnet.com/1007-9327/full/v20/i1/183.htm
Number Citing Articles
1
Rui Zhang, Xiaomei Gao, Jieliang Zuo, Beiyuan Hu, Jimeng Yang, Jing Zhao, Jinhong Chen. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathwayCancer Science 2020; 111(2): 406 doi: 10.1111/cas.14262
2
Bin Sun, Congli Hu, Zhibin Yang, Xiaofeng Zhang, Linlin Zhao, Junye Xiong, Junyong Ma, Lei Chen, Haihua Qian, Xiangji Luo, Lehua Shi, Jun Li, Xianshuo Cheng, Zhengfeng Yin. Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cellsOncotarget 2017; 8(20): 32523 doi: 10.18632/oncotarget.15808
3
Jrhau Lung, Yu-Ching Lin, Ming-Szu Hung, Yuan Yuan Jiang, Kuan-Der Lee, Paul Yann Lin, Ying Huang Tsai. A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimensLung Cancer 2016; 94: 114 doi: 10.1016/j.lungcan.2016.02.004
4
Matthew G. Hanna, Vesna Najfeld, Hanna Y. Irie, Joseph Tripodi, Anupma Nayak. Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplificationSpringerPlus 2015; 4(1) doi: 10.1186/s40064-015-1235-9
5
Enrico Franceschi, Dario De Biase, Vincenzo Di Nunno, Annalisa Pession, Alicia Tosoni, Lidia Gatto, Giovanni Tallini, Michela Visani, Raffaele Lodi, Stefania Bartolini, Alba Ariela Brandes. The clinical and prognostic role of ALK in glioblastomaPathology - Research and Practice 2021; 221: 153447 doi: 10.1016/j.prp.2021.153447
6
JIANHUA LIU, HAOSHENG JIN, HONGXIA TIAN, GUODA LIAN, SHAOJIE CHEN, JIAYU LI, XUCHAO ZHANG, DONG MA. Anaplastic lymphoma kinase protein expression predicts micrometastases and prognosis for patients with hepatocellular carcinomaOncology Letters 2016; 11(1): 213 doi: 10.3892/ol.2015.3859
7
Zhen Yu, Ronglei Zhao. Inhibition of anaplastic lymphoma kinase promotes apoptosis and suppresses proliferation in human hepatocellular carcinomaAnti-Cancer Drugs 2018; 29(6): 513 doi: 10.1097/CAD.0000000000000616
8
Anna Patrikidou, Isabelle Sinapi, Hélène Regnault, Florence Fayard, Mohamed Bouattour, Laetitia Fartoux, Sandrine Faivre, David Malka, Michel Ducreux, Valerie Boige. Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapiesInvestigational New Drugs 2014; 32(5): 1028 doi: 10.1007/s10637-014-0100-y
9
U. Peretti, R. Ferrara, S. Pilotto, S. Kinspergher, M. Caccese, A. Santo, M. Brunelli, A. Caliò, L. Carbognin, I. Sperduti, M. Garassino, M. Chilosi, A. Scarpa, G. Tortora, E. Bria. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlationsRespiratory Research 2016; 17(1) doi: 10.1186/s12931-016-0422-8
10
Federica Zito Marino, Gaetano Rocco, Alessandro Morabito, Chiara Mignogna, Martina Intartaglia, Giuseppina Liguori, Gerardo Botti, Renato Franco. A new look at the ALK gene in cancer: copy number gain and amplificationExpert Review of Anticancer Therapy 2016; 16(5): 493 doi: 10.1586/14737140.2016.1162098
11
Fang Wang, Thomas Bank, Gregory Malnassy, Maribel Arteaga, Na Shang, Annika Dalheim, Xianzhong Ding, Scott J. Cotler, Mitchell F. Denning, Michael I. Nishimura, Peter Breslin, Wei Qiu. Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survivalHepatology Communications 2018; 2(6): 732 doi: 10.1002/hep4.1181